News Releases

An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, potentially serving as a general preventative measure against future flu pandemics.

Penn Medicine researchers laud early results for CAR T therapy in a small set of patients with the autoimmune disease lupus.

To increase community-based nature initiatives and improve health in Black and brown Philadelphia neighborhoods, Penn Medicine and CHOP’s Deeply Rooted Collaborative launched a Community Green Grants program to fund 22 local nature-focused projects.

Fifty-five percent of CareConnect’s patients had an active buprenorphine prescription for treatment a month after first engaging with the program.

Researchers at the University of Pennsylvania’s Basser Center for BRCA at the Abramson Cancer Center have discovered factors that may make breast and ovarian cancers associated with BRCA1/2 gene mutations more likely to recur.

Text messages sent automatically from patients’ primary care office after hospitalization were tied to decreased odds of needing further emergency care.

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists.